PART 601—LICENSING
- SUBPART A—General Provisions (§601.2 to §601.9)
- SUBPART C—Biologics Licensing (§601.12 to §601.29)
- SUBPART D—Diagnostic Radiopharmaceuticals (§601.30 to §601.35)
- SUBPART E—Accelerated Approval of Biological Products for Serious or Life-Threatening Illnesses (§601.40 to §601.46)
- SUBPART F—Confidentiality of Information (§601.50 to §601.51)
- SUBPART G—Postmarketing Studies (§601.70 to §601.70)
- SUBPART H—Approval of Biological Products When Human Efficacy Studies Are Not Ethical or Feasible (§601.90 to §601.95)